Clinical Trials Increase the Tempo in Cardiac Rhythm Management
This article was originally published in Start Up
Executive Summary
The pace is picking up in several markets for arrhythmia management devices, according to a report published in January 2005 by Medtech Insight. Driving new growth are demographic factors, advanced technologies, and clinical trials demonstrating the cost-effectiveness of expensive implantable devicies over drug therapies.You may also be interested in...
St. Jude Medical: Dealing Its Way to the Top in AF
St. Jude Medical's recent announcement that it will acquire Endocardial Solutions represents the latest step in St. Jude's aggressive strategy to become a dominant player in the atrial fibrillation (AF) market.
Can Synthetic CBD Overcome Cannabis Stigma And Break EU Novel Foods Deadlock?
Czech firm CBDepot has filed a novel food application for synthetically made CBD in Europe, which it hopes regulators will find more palatable than those for supplements derived from the cannabis plant.
Regulatory Blessings Helping China CAR-Ts March Closer To Global Cancer Patients?
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: